Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Shares Sold by Trellus Management Company LLC

Trellus Management Company LLC lowered its position in shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Free Report) by 56.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 127,000 shares of the specialty pharmaceutical company’s stock after selling 168,000 shares during the period. Trellus […]

Related Keywords

,Commonwealth Equity Services ,Exchange Commission ,Quarter For Paratek Pharmaceuticals ,Trellus Management Company ,Nasdaq ,News Ratings For Paratek Pharmaceuticals Daily ,Paratek Pharmaceuticals Price Performance ,Paratek Pharmaceuticals Profile ,Paratek Pharmaceuticals Inc ,Paratek Pharmaceuticals ,Mackenzie Financial Corp ,Ci Private Wealth ,Jefferies Financial Group ,Free Report ,Management Company ,Equity Services ,Point Capital Management ,Street Group ,Financial Group ,Visit Holdingschannel ,Paratek Pharmaceuticals Daily ,